News – Page 1070 – Endpoints News

Celgene bags CAR-T player Juno in $9B buyout as biotech M&A suddenly explodes

8 years ago

In the latest setback to Vical/Astellas partnership, lead CMV vaccine fails a pivotal PhIII study

8 years ago

Diving deep into the hemophilia market, Sanofi strikes an $11.6B Bioverativ buyout

8 years ago

BeiGene ups offering to a whopping $750M; Celgene backing $475M raise for Agios; Avastin copycat OK'd for Europe

8 years ago

Big Pharma vet John Hohneker takes the reins at Anokion; Heptares co-founder Fiona Marshall resigns from parent ...

8 years ago

PharmaMar stock tanks after PhIII ovarian cancer study flops

8 years ago

Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma

8 years ago

AstraZeneca gives itself top marks for R&D productivity makeover — but the jury is still out

8 years ago

Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report

8 years ago

The next Emflaza: Acer Therapeutics looks to take a page out of Marathon's book

8 years ago

Carmot closes $15M round to advance diabetes drug; Argos board clears reverse stock split, moves to small cap market

8 years ago

Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo

8 years ago

Insider trading scam spurred by $11.2B Gilead deal earns a stretch in prison

8 years ago

Novartis ties a new round of biosimilar development programs to a partnership deal with India's Biocon

8 years ago

Tired of being gouged for old, cheap therapies, a consortium of hospitals is going into the drug business — NYT

8 years ago

With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology

8 years ago

Where the money is: Top 100 VCs investing in US biotechs during 2017

8 years ago

With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK

8 years ago

France's Owkin raises $11M Series A for AI-aided drug development; AstraZeneca expands discovery deal with X-Chem

8 years ago

FDA and Pentagon forge breakthrough designation agreement

8 years ago

Merck KGaA taps UK cancer research organizations to feed pipeline

8 years ago

After a bruising year, Aeterna Zentaris inks a $24M upfront US pact for growth hormone asset

8 years ago

Kymriah gets speedy reviews in US and EU as Novartis looks to swiftly expand CAR-T indications

8 years ago

Is Juno worth a $10B-$12B buyout price? Analysts see megabucks deal in the making on reported Celgene talks

8 years ago

First page Previous page 1067 1068 106910701071 1072 1073 Next page Last page